FDA Enforcement Class II Terminated

BridgePoint Medical, Stingray Catheter, REF M - 1000, Sterilized with Ethylene Oxide Gas, Prescription Only, Manufacturer BridgePoint Medical Inc. 13355 10th Ave N, Suite 110, Plymouth, MN 55441. Stingray" Catheters are intended to facilitate the intraluminal placement of conventional guidewires beyond stenotic coronary lesions (including chronic total occlusions) prior to PTCA or stent intervention. When used as part of the BridgePoint Medical System, the Stingray Catheter is intended to facilitate the intraluminal placement of conventional guidewires beyond stenotic coronary lesions (including chronic total occlusions [CTOs]) prior to PTCA or stent intervention. .

Recall: Z-2074-2012 · Reported August 1, 2012

Enforcement

Recall Number
Z-2074-2012
Event ID
62450
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Bridgepoint Medical
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
August 1, 2012
Initiation Date
June 26, 2012
Classification Date
July 24, 2012
Termination Date
September 6, 2012
Address
13355 10th Ave N, Suite #110, Minneapolis, MN, 55441-5553, United States

Description

BridgePoint Medical, Stingray Catheter, REF M - 1000, Sterilized with Ethylene Oxide Gas, Prescription Only, Manufacturer BridgePoint Medical Inc. 13355 10th Ave N, Suite 110, Plymouth, MN 55441. Stingray" Catheters are intended to facilitate the intraluminal placement of conventional guidewires beyond stenotic coronary lesions (including chronic total occlusions) prior to PTCA or stent intervention. When used as part of the BridgePoint Medical System, the Stingray Catheter is intended to facilitate the intraluminal placement of conventional guidewires beyond stenotic coronary lesions (including chronic total occlusions [CTOs]) prior to PTCA or stent intervention. .

Reason

BridgePoint Medical Inc. is voluntarily recalling Stingray Catheter, Model M1000 lots BP20121440078 and BP20121560089. BridgePoint Medical, Inc. recently determined the potential of compromised sterility assurance of the product due to a faulty pouch seal. In no case was there any reported adverse clinical event related to the problem.

Code Info

Lots affected in US: BP20121440078, BP20121560089 Lots affected OUS: BP20121510086, BP20121500080

Distribution

Worldwide distribution: USA (nationwide) including: AL, AZ, CA, CO, GA, IL, KY, MD, MN, MO, NC, NY, OR, PA, WA, and WI; and countries of: Australia and Sweden.

Quantity

95 (57 USA, 38 OUS)